Atrial fibrillation history is statistically significantly associated with adverse major clinical outcomes in ICD-implanted HF patients .
Patients with AF have a higher risk of all-cause mortality , appropriate , and inappropriate ICD interventions compared with patients with no AF history .
AIMS To assess the association between atrial fibrillation ( AF ) and all-cause mortality and implantable cardioverter-defibrillators ( ICDs ) therapies  in heart failure ( HF ) patients with reduced ejection fraction and an ICD implanted .
Reduction in inappropriate therapy and mortality through ICD programming.
BACKGROUND The implantable cardioverter-defibrillator ( ICD ) is highly effective in reducing mortality among patients at risk for fatal arrhythmias , but inappropriate ICD activations are frequent , with potential adverse effects . METHODS We r and omly assigned 1500 patients with a primary -prevention indication to receive an ICD with one of three programming configurations . The primary objective was to determine whether programmed high-rate therapy ( with a 2.5-second delay before the initiation of therapy at a heart rate of ≥200 beats per minute ) or delayed therapy ( with a 60-second delay at 170 to 199 beats per minute , a 12-second delay at 200 to 249 beats per minute , and a 2.5-second delay at ≥250 beats per minute ) was associated with a decrease in the number of patients with a first occurrence of inappropriate antitachycardia pacing or shocks , as compared with conventional programming ( with a 2.5-second delay at 170 to 199 beats per minute and a 1.0-second delay at ≥200 beats per minute ) . RESULTS During an average follow-up of 1.4 years , high-rate therapy and delayed ICD therapy , as compared with conventional device programming , were associated with reductions in a first occurrence of inappropriate therapy ( hazard ratio with high-rate therapy vs. conventional therapy , 0.21 ; 95 % confidence interval [ CI ] , 0.13 to 0.34 ; P<0.001 ; hazard ratio with delayed therapy vs. conventional therapy , 0.24 ; 95 % CI , 0.15 to 0.40 ; P<0.001 ) and reductions in all-cause mortality ( hazard ratio with high-rate therapy vs. conventional therapy , 0.45 ; 95 % CI , 0.24 to 0.85 ; P=0.01 ; hazard ratio with delayed therapy vs. conventional therapy , 0.56 ; 95 % CI , 0.30 to 1.02 ; P=0.06 ) . There were no significant differences in procedure-related adverse events among the three treatment groups . CONCLUSIONS Programming of ICD therapies for tachyarrhythmias of 200 beats per minute or higher or with a prolonged delay in therapy at 170 beats per minute or higher , as compared with conventional programming , was associated with reductions in inappropriate therapy and all-cause mortality during long-term follow-up . ( Funded by Boston Scientific ; MADIT-RIT Clinical Trials.gov number , NCT00947310 . )
Atrial fibrillation history is statistically significantly associated with adverse major clinical outcomes in ICD-implanted HF patients .
Patients with AF have a higher risk of all-cause mortality , appropriate , and inappropriate ICD interventions compared with patients with no AF history .
AIMS To assess the association between atrial fibrillation ( AF ) and all-cause mortality and implantable cardioverter-defibrillators ( ICDs ) therapies  in heart failure ( HF ) patients with reduced ejection fraction and an ICD implanted .